Science Explorer Back to mapMap
Discussion
Institution · Biomedical Frontiers (United States)

Most cited papers from Biomedical Frontiers (United States)

Biomedical Frontiers (United States)

What are the most cited papers from Biomedical Frontiers (United States)?

The most cited paper from Biomedical Frontiers (United States) is "Modulation of deferoxamine toxicity and clearance by covalent attachment to biocompatible polymers." (Philip E. Hallaway, John W. Eaton, S. Scott Panter et al., 1989), with 188 citations. Next come "Abnormal iron distribution in infants of diabetic mothers: Spectrum and maternal antecedents" (156) and "Principles of tissue engineering applied to programmable osteogenesis" (144).

Showing 43 of 43 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Modulation of deferoxamine toxicity and clearance by covalent attachment to biocompatible polymers. Philip E. Hallaway, John W. Eaton, S. Scott Panter et al. · Proceedings of the National Academy of Sciences Open access Dec 1989 188
2 Abnormal iron distribution in infants of diabetic mothers: Spectrum and maternal antecedents Michael Georgieff, Mark B. Landon, Marla M. Mills et al. · The Journal of Pediatrics Sep 1990 156
3 Principles of tissue engineering applied to programmable osteogenesis John H. Brekke, Jeffrey M. Toth · Journal of Biomedical Materials Research 1998 144
4 White Paper on Early Critical Care Services in Low Resource Settings Lia Ilona Losonczy et al. · Annals of Global Health Open access 2021 76
5 Electrodes and multiple electrode systems for radiofrequency ablation: a proposal for updated terminology Stefaan Mulier, Yi Miao, Peter Mulier et al. · European Radiology 11 Feb 2005 68
6 Acute iron poisoning. Rescue with macromolecular chelators. John R. Mahoney, Philip E. Hallaway, Bo E. Hedlund et al. · Journal of Clinical Investigation Open access Oct 1989 63
7 First human studies with a high-molecular-weight iron chelator Paul R. Dragsten, Philip E. Hallaway, Gregory J. Hanson et al. · Journal of Laboratory and Clinical Medicine 2000 58
8 Radiomorphometry and biomechanical assessment of recombinant human bone morphogenetic protein 2 and polymer in rabbit radius ostectomy model Donna L. Wheeler, David L. Chamberland, John Schmitt et al. · Journal of Biomedical Materials Research 1998 51
9 Extracellular iron chelators protect kidney cells from hypoxia/reoxygenation Mark S. Paller, Bo E. Hedlund · Free Radical Biology and Medicine Dec 1994 49
10 Iron deprivation increases erythropoietin production in vitro, in normal subjects and patients with malignancy Pamela J. Kling, Paul R. Dragsten, Robin A. Roberts et al. · British Journal of Haematology Nov 1996 42
11 Phase Ib clinical trial of starch‐conjugated deferoxamine (40SD02): a novel long‐acting iron chelator Paul Harmatz, Robert W. Grady, Paul R. Dragsten et al. · British Journal of Haematology Open access 3 Jul 2007 41
12 Learning from Child Protection Systems Mapping and Analysis in West Africa: Research and Policy Implications Alexander Krueger, Guy Thompstone, Vimala Crispin · Global Policy 29 Jul 2013 37
13 Policy design: From tools to patches Michael P. Howlett, Ishani Mukherjee · Canadian Public Administration Open access Mar 2017 33
14 Circadian coordination of cancer growth and metastatic spread William J.M. Hrushesky, Bruce R. Lester, Donald R. Lannin · International Journal of Cancer Open access 29 Oct 1999 24
15 Shared genetic susceptibility of Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetes mellitus: contributions of HLA and haptoglobin Stephen S. Rich, S. Scott Panter, F. C. Goetz et al. · Diabetologia Open access May 1991 22
16 High-dose systemic iron chelation attenuates reperfusion injury Bo E. Hedlund, Philip E. Hallaway · Biochemical Society Transactions May 1993 19
17 Engineering analysis and development of the spheroid reservoir bioartificial liver Malcom B. McIntosh, Stephen M. Corner, Bruce P. Amiot et al. Conference paperOpen access Sep 2009 19
18 Practical Illustrations in Tissue Engineering: Surgical Considerations Relevant to the Implantation of Osteoinductive Devices E. VÖGELIN, NEIL FORD JONES, Jerry I. Huang et al. · Tissue Engineering Aug 2000 14
19 High-Dose Iron-Chelator Therapy During Reperfusion with Deferoxamine-Hydroxyethyl Starch Conjugate Fails to Reduce Canine Infarct Size Edward Joseph Lesnefsky, Bo E. Hedlund, Philip E. Hallaway et al. · Journal of Cardiovascular Pharmacology Oct 1990 13
20 Hemodynamic Effects of Intraatrial Administration of Deferoxamine or Deferoxamine-Pentafraction Conjugate to Conscious Dogs John R. Forder, Thomas B. McClanahan, Kim P. Gallagher et al. · Journal of Cardiovascular Pharmacology Nov 1990 13
21 Assessment of microvascular integrity in the isolated perfused rat liver by contrast‐enhanced MRI. Attenuation of reperfusion injury by conjugated deferoxamine Jean‐Marie Colet, Erol Cetiner, Bo E. Hedlund et al. · Magnetic Resonance in Medicine Open access Nov 1996 12
22 Failure to alter the course of acute myelogenous leukemia in the rat with subcutaneous deferoxamine Julie Blatt, Florence Boegel, Bo E. Hedlund et al. · Leukemia Research 1991 11
23 Temporary treatment with sirolimus and low-trough cyclosporine prevents acute islet allograft rejection, and combination with starch-conjugated deferoxamine promotes islet engraftment in the preclinical pig model Satoshi Shibata, S Matsumoto, Junichiro Sageshima et al. · Transplantation Proceedings Feb 2001 10
24 Heterotope und orthotope Knochenbildung mit einem vaskularisierten Periostlappen, einer Matrix und rh-BMP-2 (bone morphogenetic protein) im Rattenmodell Esther Vögelin, John H. Brekke, NEIL FORD JONES · Oral and Maxillofacial Surgery Sep 2000 10
25 Validating MDS Data about Risk Factors for Perineal Dermatitis by Comparing With Nursing Home Records Anna M. Toth, Donna Zimmaro Bliss, Kay Savik et al. · Journal of Gerontological Nursing Open access May 2008 9
26 Role of iron and oxygen radicals in hemorrhage and shock Bo E. Hedlund, Philip E. Hallaway · Journal of Molecular Medicine Dec 1991 8
27 The Effect of the MNRI Method on Neurotransmitter Biomarkers of Individuals with Neurodevelopmental Disorders Clayton Bell, Jordan Whitney, Trina Deiss et al. · Neuroscience &amp Medicine Open access 2019 6
28 A reassessment of fasting plasma glucose concentrations in population screening for diabetes mellitus in a community of northern European ancestry: the Wadena City Health Study Jason Clements, Lindsey French, James R. Boen et al. · Acta Diabetologica 1994 6
29 2000 survey of window manufacturers on the subject of switchable glass Michael R. LaPointe, Gregory M. Sottile · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE Conference paper 13 Nov 2001 6
30 Comparative Analysis of Aromatic Sulfonated Polyamide and Perfluorinated Sulfonic Acid Ionomers: Implications for Polymer Electrolyte Fuel Cell Performance Xiao Pei Gao, Buyi Bian, Noboru Ohta et al. · ACS Physical Chemistry Au Open access 5 Sep 2025 3
31 Frontiers of Medicinal Chemistry Derong Ding · Medicinal Chemistry Open access 2016 3
32 High Molecular Weight Forms of Deferoxamine: Novel Therapeutic Agents for Treatment of Iron-Mediated Tissue Injury Bo E. Hedlund, Philip E. Hallaway, John R. Mahoney · Advances in experimental medicine and biology Book chapter 1990 3
33 Preclinical characterization of EGT710, an oral non-peptidomimetic reversible covalent SARS-CoV-2 main protease inhibitor Stephanie A. Moquin et al. · npj Drug Discovery. Open access 28 Nov 2025 2
34 Emerging Commercial Remote Sensing: Entrepreneurial Perspective Scott Hubbard, Ken Davidian, Dan López et al. · New Space Mar 2015 2
35 Proposed Toxic Oxidant Inhibitors Fail to Reduce Brain Edema Kevin D Judy, G. B. Bulkley, Bo E. Hedlund et al. Book chapter 1994 2
36 Acute Resuscitation and Antioxidant Therapy Bo E. Hedlund, Philip E. Hallaway Book chapter 1993 1
37 Proof of Concept: Development of a Mitral Annuloplasty Ring With Crosshatch Net Benjamin D. Seadler, David L. Joyce, James Zelten et al. · Innovations Technology and Techniques in Cardiothoracic and Vascular Surgery Mar 2024 0
38 FIRST HUMAN TESTING OF PERFUSOL, A NOVEL ANTI-OXIDANT COMPOUND FOR USE IN FLUID RESUSCITATION. Paul R. Dragsten, G. J. Hanson, Philip E. Hallaway et al. · Shock Jun 1995 0
39 Pharmacokinetic and Toxicological Results of a 28-Day Multiple Dose Study of Starch-Conjugated Deferoxamine (S-DFO, 40SD02) in Iron-Loaded Dogs. Robert W. Grady, James P. Bakke, Karen L. Steinmetz et al. · Blood 16 Nov 2007 0
40 Iron chelation by gene therapy: a twenty-first century challenge for molecular medicine Bo E. Hedlund · Journal of Laboratory and Clinical Medicine Sep 1997 0
41 Paradigm Shift Allows for Readily Available Therapeutic Hypothermia Treatment of the Head Region1 Michael Zumbrunnen · Journal of Medical Devices 6 Mar 2014 0
42 Nonclinical Development of Radiopharmaceuticals: Regulatory Considerations for the United States Food and Drug Administration Sandra Wilson Book chapter 2004 0
43 GTP Binding Proteins in Platelets Bruce R. Lester Book chapter 1999 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.